| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-08-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $11.40M | $10.11M | $9.93M | $10.29M | $4.04M | $7.44M |
| R&D | $5.42M | $5.99M | $5.70M | $4.32M | $1.94M | $2.84M |
| SG&A | $5.98M | $4.12M | $4.23M | $5.96M | $2.10M | $3.52M |
| Operating Income | -$11.40M | -$10.11M | -$9.93M | -$10.29M | -$4.04M | -$7.44M |
| Interest Expense | $194.00K | $0.00 | $0.00 | $5.00K | $0.00 | $0.00 |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$12.88M | -$9.83M | -$9.29M | -$10.08M | -$4.04M | -$7.44M |
| EPS (basic) | – | – | – | – | – | – |
| EPS (diluted) | -12.5200 | -3.0500 | -3.1400 | – | – | – |
| Shares (diluted) | $1.03M | $3.22M | $2.96M | – | – | – |